HPV Vaccines – the road to development of prophylactic HPV vaccination Your browser doesn’t support HTML5 video. Here is a link to the video instead. Published: 29th Jul '10 Channel: Professionals Professor Margaret Stanley OBE, Department of Pathology, University of Cambridge Leave a Comment Related Films Filmed for the Cambridge Pathways Project. Kate Burton is a Consultant Radiographer, Kate tells us about her role and the radiotherapy department. Consultant Radiographer Filmed at CCLG Summer Meeting on 11-12 June 2012 at Lakeside Centre, Aston Business School in Birmingham. Consultant Paediatric Pathologist Anna Kelsey gives an update on the pathology group. CCLG – Pathology Group Professor Henry Kitchener, School of Cancer and Imaging Science, University of Manchester HPV – clinical efficacy of prophylactic vaccines and the national UK programme Dr Maggie Cruickshank, Senior Clinical Lecturer in Gynaecology, University of Aberdeen Consider the implications of HPV vaccinations for cervical screening Professor Ronnie Barr Professor of Pediatrics, Pathology & Medicine, McMaster University, Hamilton, Canada Accrual to clinical trials as the standard of care – challeges and opportunities: Canadian and USA perspectives
Filmed for the Cambridge Pathways Project. Kate Burton is a Consultant Radiographer, Kate tells us about her role and the radiotherapy department. Consultant Radiographer
Filmed at CCLG Summer Meeting on 11-12 June 2012 at Lakeside Centre, Aston Business School in Birmingham. Consultant Paediatric Pathologist Anna Kelsey gives an update on the pathology group. CCLG – Pathology Group
Professor Henry Kitchener, School of Cancer and Imaging Science, University of Manchester HPV – clinical efficacy of prophylactic vaccines and the national UK programme
Dr Maggie Cruickshank, Senior Clinical Lecturer in Gynaecology, University of Aberdeen Consider the implications of HPV vaccinations for cervical screening
Professor Ronnie Barr Professor of Pediatrics, Pathology & Medicine, McMaster University, Hamilton, Canada Accrual to clinical trials as the standard of care – challeges and opportunities: Canadian and USA perspectives